RITE AID CORPORATION

(RAD)
  Report
Delayed Nyse  -  04:00 2022-08-08 pm EDT
9.090 USD   +1.11%
08/04Rite Aid Opens Online Scheduling for Flu Vaccines at All Locations
BU
07/29Rite Aid Shares Surge Amid Heavy Volume After Reelection of Board Members
MT
07/29RITE AID COULD BE SUBJECT TO ACTIVIST INTEREST : Dealreporter
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Rite Aid to Start Administering Pfizer's Booster Shot to Chidren Ages 5 to 11

05/20/2022 | 01:16pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
PFIZER, INC. 0.61% 49.57 Delayed Quote.-16.56%
RITE AID CORPORATION 1.11% 9.09 Delayed Quote.-38.80%
All news about RITE AID CORPORATION
08/04Rite Aid Opens Online Scheduling for Flu Vaccines at All Locations
BU
07/29Rite Aid Shares Surge Amid Heavy Volume After Reelection of Board Members
MT
07/29RITE AID COULD BE SUBJECT TO ACTIVIS : Dealreporter
MT
07/28RITE AID CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote..
AQ
07/28Declaration of voting results by Rite Aid Corporation
CI
07/20Rite Aid Releases Fourth Annual Environmental, Social and Governance Report
BU
07/20RITE AID : Sustainability Report - 2022
PU
07/19Rite Aid, Quest Diagnostics to Provide Access to COVID-19 PCR Testing
MT
07/19Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide
BU
07/13Rite Aid Opens New Modern Headquarters in Philadelphia's Navy Yard
BU
More news
Analyst Recommendations on RITE AID CORPORATION
More recommendations
Financials (USD)
Sales 2023 23 753 M - -
Net income 2023 -224 M - -
Net Debt 2023 2 660 M - -
P/E ratio 2023 -2,21x
Yield 2023 -
Capitalization 506 M 506 M -
EV / Sales 2023 0,13x
EV / Sales 2024 0,14x
Nbr of Employees 53 000
Free-Float 96,0%
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 3
Last Close Price 9,09 $
Average target price 6,33 $
Spread / Average Target -30,3%
EPS Revisions
Managers and Directors
Heyward R. Donigan President, Chief Executive Officer & Director
Matthew C. Schroeder Chief Financial Officer & Executive Vice President
Bruce G. Bodaken Chairman
Justin Mennen Chief Digital & Technology Officer
Arun Nayar Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RITE AID CORPORATION-38.80%506
RAIA DROGASIL S.A.-8.64%7 018
AIN HOLDINGS INC.32.29%1 967
PETMED EXPRESS, INC.-15.48%432
QOL HOLDINGS CO., LTD.3.93%396
HLS THERAPEUTICS INC.-15.27%319